UPDATE 2-Biogen's Spinraza fuels third-quarter profit beat
October 23, 2018 at 08:06 AM EDT
Biogen Inc beat analysts' estimates for third-quarter profit on Tuesday, driven by double-digit sales growth of its muscle disease treatment Spinraza.
